Lilly(Eli) & Company
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable.
Profit margin of 31.7% — that's well above average.
Current Price
$955.19
+0.20%GoodMoat Value
$1015.63
6.3% undervaluedLilly(Eli) & Company (LLY) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Lilly(Eli) & Company's financial performance and position as a Healthcare company.
Trailing twelve-month (TTM) revenue is $65.18B. Gross profit (TTM) is $54.13B. EBITDA is $27.73B. Earnings per share (EPS) is $22.95. The P/E ratio is 43.75. Market capitalization is $903.02B.
Free cash flow (FCF) is $8.97B. FCF growth rate is 15.38%. EPS growth CAGR is 15.38%. Weighted average cost of capital (WACC) is 10.00%.
Historical revenue data covers 7 years from FY19 to FY25. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.
Use Lilly(Eli) & Company's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.
